Hormonal Imbalances in Prader–Willi and Schaaf–Yang Syndromes Imply the Evolution of Specific Regulation of Hypothalamic Neuroendocrine Function in Mammals

The hypothalamus regulates fundamental aspects of physiological homeostasis and behavior, including stress response, reproduction, growth, sleep, and feeding, several of which are affected in patients with Prader-Willi (PWS) and Schaaf-Yang syndrome (SYS). PWS is caused by paternal deletion, maternal uniparental disomy, or imprinting defects that lead to loss of expression of a maternally imprinted region of chromosome 15 encompassing non-coding RNAs and five protein-coding genes; SYS patients have a mutation in one of them, MAGEL2. Throughout life, PWS and SYS patients suffer from musculoskeletal deficiencies, intellectual disabilities, and hormonal abnormalities, which lead to compulsive behaviors like hyperphagia and temper outbursts. Management of PWS and SYS is mostly symptomatic and cures for these debilitating disorders do not exist, highlighting a clear, unmet medical need. Research over several decades into the molecular and cellular roles of PWS genes has uncovered that several impinge on the neuroendocrine system. In this review, we will discuss the expression and molecular functions of PWS genes, connecting them with hormonal imbalances in patients and animal models. Besides the observed hormonal imbalances, we will describe the recent findings about how the loss of individual genes, particularly MAGEL2, affects the molecular mechanisms of hormone secretion. These results suggest that MAGEL2 evolved as a mammalian-specific regulator of hypothalamic neuroendocrine function.

[1]  C. Camerino Oxytocin’s Regulation of Thermogenesis May Be the Link to Prader–Willi Syndrome , 2023, Current issues in molecular biology.

[2]  S. Einfeld,et al.  The relationship between endogenous oxytocin and vasopressin levels and the Prader-Willi syndrome behaviour phenotype , 2023, Frontiers in Endocrinology.

[3]  S. Gygi,et al.  MKRN3 inhibits puberty onset via interaction with IGF2BP1 and regulation of hypothalamic plasticity , 2023, JCI insight.

[4]  K. Szamotulska,et al.  Circulating Levels of Nesfatin-1 and Spexin in Children with Prader-Willi Syndrome during Growth Hormone Treatment and Dietary Intervention , 2023, Nutrients.

[5]  M. Butler Prader–Willi Syndrome and Chromosome 15q11.2 BP1-BP2 Region: A Review , 2023, International journal of molecular sciences.

[6]  M. Krebs,et al.  Prader–Willi syndrome: Symptoms and topiramate response in light of genetics , 2023, Frontiers in Neuroscience.

[7]  Rodney C. Samaco,et al.  Truncated rat Magel2 modelled for the study of Schaaf-Yang syndrome alters select behavioral and physiological outcomes. , 2023, Disease models & mechanisms.

[8]  K. Demir,et al.  Positive effects of ketogenic diet on weight control in children with obesity due to Prader–Willi syndrome , 2022, Clinical endocrinology.

[9]  Kyoko Takano,et al.  A nationwide survey of Schaaf-Yang syndrome in Japan , 2022, Journal of Human Genetics.

[10]  Simon C Watkins,et al.  Insulin secretion deficits in a Prader-Willi syndrome β-cell model are associated with a concerted downregulation of multiple endoplasmic reticulum chaperones , 2022, bioRxiv.

[11]  A. Basak,et al.  Proteins and proteases of Prader–Willi syndrome: a comprehensive review and perspectives , 2022, Bioscience reports.

[12]  D. Molnár,et al.  Prader–Willi Syndrome: Possibilities of Weight Gain Prevention and Treatment , 2022, Nutrients.

[13]  J. Gaiarsa,et al.  Early life oxytocin treatment improves thermo-sensory reactivity and maternal behavior in neonates lacking the autism-associated gene Magel2 , 2022, Neuropsychopharmacology.

[14]  D. Turkkahraman,et al.  Serum alpha-melanocyte-stimulating hormone (a-MSH), brain-derived neurotrophic factor (BDNF), and agouti-related protein (AGRP) levels in children with Prader-Willi or Bardet-Biedl syndromes , 2022, Journal of Endocrinological Investigation.

[15]  E. Jantscher-Krenn,et al.  Placental Endocrine Activity: Adaptation and Disruption of Maternal Glucose Metabolism in Pregnancy and the Influence of Fetal Sex , 2021, International journal of molecular sciences.

[16]  M. Butler,et al.  Hypogonadism in Adult Males with Prader-Willi Syndrome—Clinical Recommendations Based on a Dutch Cohort Study, Review of the Literature and an International Expert Panel Discussion , 2021, Journal of clinical medicine.

[17]  J. Gaiarsa,et al.  Oxytocin administration in neonates shapes hippocampal circuitry and restores social behavior in a mouse model of autism , 2021, Molecular Psychiatry.

[18]  D. Tautz,et al.  Natural copy number variation of tandemly repeated regulatory SNORD RNAs leads to individual phenotypic differences in mice , 2021, Molecular ecology.

[19]  J. Fletcher,et al.  E3 ligase MKRN3 is a tumor suppressor regulating PABPC1 ubiquitination in non–small cell lung cancer , 2021, The Journal of experimental medicine.

[20]  S. Nelson,et al.  Mosaic de novo SNRPN gene variant associated with Prader-Willi syndrome , 2021, Journal of Medical Genetics.

[21]  J. Salles,et al.  SNORD116 and growth hormone therapy impact IGFBP7 in Prader–Willi syndrome , 2021, Genetics in Medicine.

[22]  E. Fliers,et al.  Hypothalamic neuropeptides and neurocircuitries in Prader Willi syndrome , 2021, Journal of neuroendocrinology.

[23]  C. Schaaf,et al.  A retrospective analysis of growth hormone therapy in children with Schaaf–Yang syndrome , 2021, Clinical genetics.

[24]  J. Brosius,et al.  A Comprehensive Review of Genetically Engineered Mouse Models for Prader-Willi Syndrome Research , 2021, International journal of molecular sciences.

[25]  Xiaoxu Tian,et al.  MKRN3-mediated ubiquitination of Poly(A)-binding proteins modulates the stability and translation of GNRH1 mRNA in mammalian puberty , 2021, Nucleic acids research.

[26]  C. Höybye,et al.  Prader–Willi Syndrome and Hypogonadism: A Review Article , 2021, International journal of molecular sciences.

[27]  M. Tauber,et al.  Endocrine disorders in Prader-Willi syndrome: a model to understand and treat hypothalamic dysfunction. , 2021, The lancet. Diabetes & endocrinology.

[28]  N. Longo,et al.  Hypogonadism in Patients with Prader Willi Syndrome: A Narrative Review , 2021, International journal of molecular sciences.

[29]  M. Maghnie,et al.  Sleep disorders in Prader-Willi syndrome, evidence from animal models and humans. , 2021, Sleep medicine reviews.

[30]  C. Schaaf,et al.  The adult phenotype of Schaaf-Yang syndrome , 2020, Orphanet Journal of Rare Diseases.

[31]  K. Fon Tacer,et al.  Emerging roles of the MAGE protein family in stress response pathways , 2020, The Journal of Biological Chemistry.

[32]  J. Diedrich,et al.  Loss of MAGEL2 in Prader-Willi syndrome leads to decreased secretory granule and neuropeptide production , 2020, JCI insight.

[33]  Stormy J. Chamberlain,et al.  Prader-Willi syndrome: reflections on seminal studies and future therapies , 2020, Open Biology.

[34]  M. Hill,et al.  Systematic investigation of imprinted gene expression and enrichment in the mouse brain explored at single-cell resolution , 2020, bioRxiv.

[35]  Jia-Da Li,et al.  Necdin regulates BMAL1 stability and circadian clock through SGT1-HSP90 chaperone machinery , 2020, Nucleic acids research.

[36]  Shondra M. Pruett-Miller,et al.  Translational Repression of G3BP in Cancer and Germ Cells Suppresses Stress Granules and Enhances Stress Tolerance. , 2020, Molecular cell.

[37]  Hilal Sekizkardes,et al.  Heterozygous deletions in MKRN3 cause central precocious puberty without Prader-Willi Syndrome. , 2020, The Journal of clinical endocrinology and metabolism.

[38]  C. A. Toro,et al.  MKRN3 inhibits the reproductive axis through actions in kisspeptin-expressing neurons. , 2020, The Journal of clinical investigation.

[39]  S. McCandless,et al.  SUN-604 U.S. Prevalence & Mortality of Prader-Willi Syndrome: A Population-Based Study of Medical Claims , 2020, Journal of the Endocrine Society.

[40]  C. Alves,et al.  Prader-Willi syndrome: endocrine manifestations and management , 2020, Archives of endocrinology and metabolism.

[41]  E. Hovig,et al.  Loss of Snord116 impacts lateral hypothalamus, sleep and food-related behaviors. , 2020, JCI insight.

[42]  M. Min,et al.  Firing activity of locus coeruleus noradrenergic neurons decreases in necdin-deficient mice, an animal model of Prader–Willi syndrome , 2020, Journal of Neurodevelopmental Disorders.

[43]  Yixue Li,et al.  MKRN3 regulates the epigenetic switch of mammalian puberty via ubiquitination of MBD3 , 2020, National science review.

[44]  Igor Ribeiro Ferreira,et al.  Genotype-Phenotype Relationships and Endocrine Findings in Prader-Willi Syndrome , 2019, Front. Endocrinol..

[45]  M. Butler,et al.  Prader-Willi Syndrome - Clinical Genetics, Diagnosis and Treatment Approaches: An Update , 2019, Current pediatric reviews.

[46]  Shondra M. Pruett-Miller,et al.  MAGE cancer-testis antigens protect the mammalian germline under environmental stress , 2019, Science Advances.

[47]  R. Carroll,et al.  MKRN3 Mutations in Central Precocious Puberty: A Systematic Review and Meta-Analysis , 2019, Journal of the Endocrine Society.

[48]  R. Wevrick,et al.  Preclinical Testing in Translational Animal Models of Prader-Willi Syndrome: Overview and Gap Analysis , 2019, Molecular therapy. Methods & clinical development.

[49]  M. Varjosalo,et al.  MKRN3 Interacts With Several Proteins Implicated in Puberty Timing but Does Not Influence GNRH1 Expression , 2019, Front. Endocrinol..

[50]  N. Benvenisty,et al.  Genomic Imprinting and Physiological Processes in Mammals , 2019, Cell.

[51]  D. Atasoy,et al.  Inactivation of Magel2 suppresses oxytocin neurons through synaptic excitation-inhibition imbalance , 2019, Neurobiology of Disease.

[52]  B. Crespi,et al.  Baby food and bedtime: Evidence for opposite phenotypes from different genetic and epigenetic alterations in Prader-Willi and Angelman syndromes , 2019, SAGE open medicine.

[53]  J. Charrow,et al.  Schaaf‐Yang syndrome overview: Report of 78 individuals , 2018, American journal of medical genetics. Part A.

[54]  S. Duarte,et al.  Loss of hierarchical imprinting regulation at the Prader–Willi/Angelman syndrome locus in human iPSCs , 2018, Human molecular genetics.

[55]  E. Burstein,et al.  Endosomal receptor trafficking: Retromer and beyond , 2018, Traffic.

[56]  K. Fisher,et al.  The relationship between metabolic syndrome, cytokines and physical activity in obese youth with and without Prader-Willi syndrome , 2018, Journal of pediatric endocrinology & metabolism : JPEM.

[57]  D. J. Driscoll,et al.  Molecular genetic classification in Prader-Willi syndrome: a multisite cohort study , 2018, Journal of Medical Genetics.

[58]  Jack Humphrey,et al.  A Transcriptomic Signature of the Hypothalamic Response to Fasting and BDNF Deficiency in Prader-Willi Syndrome , 2018, Cell reports.

[59]  C. Schaaf,et al.  Hormonal, metabolic and skeletal phenotype of Schaaf-Yang syndrome: a comparison to Prader-Willi syndrome , 2018, Journal of Medical Genetics.

[60]  S. O’Rahilly,et al.  Hypothalamic loss of Snord116 recapitulates the hyperphagia of Prader-Willi syndrome , 2018, The Journal of clinical investigation.

[61]  J. Tavernier,et al.  The Prader-Willi syndrome proteins MAGEL2 and necdin regulate leptin receptor cell surface abundance through ubiquitination pathways , 2017, Human molecular genetics.

[62]  P. Gaspar,et al.  Necdin shapes serotonergic development and SERT activity modulating breathing in a mouse model for Prader-Willi syndrome , 2017, eLife.

[63]  Jinsup Kim,et al.  Prevalence and risk factors for type 2 diabetes mellitus with Prader–Willi syndrome: a single center experience , 2017, Orphanet Journal of Rare Diseases.

[64]  P. Lundquist,et al.  A novel deletion of SNURF/SNRPN exon 1 in a patient with Prader-Willi-like phenotype. , 2017, European journal of medical genetics.

[65]  Huifang Liu,et al.  Mkrn3 functions as a novel ubiquitin E3 ligase to inhibit Nptx1 during puberty initiation , 2017, Oncotarget.

[66]  P. Potts,et al.  Cellular and disease functions of the Prader-Willi Syndrome gene MAGEL2. , 2017, The Biochemical journal.

[67]  C. Schaaf,et al.  Magel2 knockout mice manifest altered social phenotypes and a deficit in preference for social novelty , 2017, Genes, brain, and behavior.

[68]  M. Butler,et al.  Survival Trends from the Prader-Willi Syndrome Association (USA) 40-Year Mortality Survey , 2017, Genetics in Medicine.

[69]  D. J. Driscoll,et al.  Oxytocin treatment in children with Prader–Willi syndrome: A double‐blind, placebo‐controlled, crossover study , 2017, American journal of medical genetics. Part A.

[70]  Yuanyuan Xie,et al.  Development of the hypothalamus: conservation, modification and innovation , 2017, Development.

[71]  D. J. Driscoll,et al.  Deficiency in prohormone convertase PC1 impairs prohormone processing in Prader-Willi syndrome , 2016, The Journal of clinical investigation.

[72]  M. Butler,et al.  Causes of Death in Prader-Willi Syndrome: Prader-Willi Syndrome Association (USA) 40-Year Mortality Survey , 2016, Genetics in Medicine.

[73]  M. Rigla,et al.  Lack of Postprandial Peak in Brain-Derived Neurotrophic Factor in Adults with Prader-Willi Syndrome , 2016, PloS one.

[74]  D. J. Driscoll,et al.  Higher plasma orexin a levels in children with Prader–Willi syndrome compared with healthy unrelated sibling controls , 2016, American journal of medical genetics. Part A.

[75]  C. Cheon Genetics of Prader-Willi syndrome and Prader-Will-Like syndrome , 2016, Annals of pediatric endocrinology & metabolism.

[76]  A. Latronico,et al.  A boy with Prader-Willi syndrome: unmasking precocious puberty during growth hormone replacement therapy , 2016, Archives of endocrinology and metabolism.

[77]  A. Sartorio,et al.  Growth hormone therapy for Prader–willi syndrome: challenges and solutions , 2016, Therapeutics and clinical risk management.

[78]  J. Rosenfeld,et al.  The phenotypic spectrum of Schaaf-Yang syndrome – 18 new affected individuals from 14 families , 2016, Genetics in Medicine.

[79]  D. J. Driscoll,et al.  Elevated plasma oxytocin levels in children with Prader–Willi syndrome compared with healthy unrelated siblings , 2016, American journal of medical genetics. Part A.

[80]  C. Schaaf,et al.  Prader-Willi Syndrome and Schaaf-Yang Syndrome: Neurodevelopmental Diseases Intersecting at the MAGEL2 Gene , 2016, Diseases.

[81]  S. Nishino,et al.  Decline of CSF orexin (hypocretin) levels in Prader–Willi syndrome , 2016, American journal of medical genetics. Part A.

[82]  L. Campbell,et al.  Snord116 is critical in the regulation of food intake and body weight , 2016, Scientific Reports.

[83]  L. Zwaigenbaum,et al.  Autism spectrum disorder in Prader–Willi syndrome: A systematic review , 2015, American journal of medical genetics. Part A.

[84]  V. Gross‐Tsur,et al.  Sexual dichotomy of gonadal function in Prader-Willi syndrome from early infancy through the fourth decade. , 2015, Human reproduction.

[85]  I. Gut,et al.  Truncating Mutations of MAGEL2, a Gene within the Prader-Willi Locus, Are Responsible for Severe Arthrogryposis. , 2015, American journal of human genetics.

[86]  Evdokia Anagnostou,et al.  Oxytocin and vasopressin: linking pituitary neuropeptides and their receptors to social neurocircuits , 2015, Front. Neurosci..

[87]  J. Rosenfeld,et al.  USP7 Acts as a Molecular Rheostat to Promote WASH-Dependent Endosomal Protein Recycling and Is Mutated in a Human Neurodevelopmental Disorder. , 2015, Molecular cell.

[88]  D. J. Driscoll,et al.  EVALUATION OF PLASMA SUBSTANCE P AND BETA-ENDORPHIN LEVELS IN CHILDREN WITH PRADER-WILLI SYNDROME. , 2015, The Journal of rare disorders.

[89]  Ying Zhang,et al.  Spexin peptide is expressed in human endocrine and epithelial tissues and reduced after glucose load in type 2 diabetes , 2015, Peptides.

[90]  M. Butler,et al.  Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings , 2015, Journal of Endocrinological Investigation.

[91]  M. Andermann,et al.  Ghrelin , 2015, Molecular metabolism.

[92]  D. J. Driscoll,et al.  Hyperghrelinemia in Prader‐Willi syndrome begins in early infancy long before the onset of hyperphagia , 2015, American journal of medical genetics. Part A.

[93]  A. Riva,et al.  Influence of the Prader-Willi syndrome imprinting center on the DNA methylation landscape in the mouse brain , 2014, Epigenetics.

[94]  B. Whitelaw,et al.  Promoter characterization and functional association with placenta of porcine MAGEL2. , 2014, Gene.

[95]  J. Peters The role of genomic imprinting in biology and disease: an expanding view , 2014, Nature Reviews Genetics.

[96]  J. Cavaille,et al.  Highly restricted deletion of the SNORD116 region is implicated in Prader–Willi Syndrome , 2014, European Journal of Human Genetics.

[97]  Robert N. Plasschaert,et al.  Genomic imprinting in development, growth, behavior and stem cells , 2014, Development.

[98]  S. Bens,et al.  Clinical phenotypes of MAGEL2 mutations and deletions , 2014, Orphanet Journal of Rare Diseases.

[99]  J. Hirschhorn,et al.  Central precocious puberty that appears to be sporadic caused by paternally inherited mutations in the imprinted gene makorin ring finger 3. , 2014, The Journal of clinical endocrinology and metabolism.

[100]  A. Meyer,et al.  The Imprinted NPAP1 Gene in the Prader–Willi Syndrome Region Belongs to a POM121-Related Family of Retrogenes , 2014, Genome biology and evolution.

[101]  Hae-sang Lee,et al.  Central precocious puberty in a girl with Prader-Willi syndrome , 2013, Journal of pediatric endocrinology & metabolism : JPEM.

[102]  A. Gautreau,et al.  Retromer-mediated endosomal protein sorting: all WASHed up! , 2013, Trends in cell biology.

[103]  B. Peters,et al.  Truncating mutations of MAGEL2cause Prader-Willi phenotypes and autism , 2013, Nature Genetics.

[104]  C. Deal,et al.  Thyroid function from birth to adolescence in Prader-Willi syndrome. , 2013, The Journal of pediatrics.

[105]  F. Michel,et al.  Stochastic Loss of Silencing of the Imprinted Ndn/NDN Allele, in a Mouse Model and Humans with Prader-Willi Syndrome, Has Functional Consequences , 2013, PLoS genetics.

[106]  A. Salvatoni,et al.  Central adrenal insufficiency in young adults with Prader‐Willi Syndrome , 2013, Clinical endocrinology.

[107]  J. Hirschhorn,et al.  Central precocious puberty caused by mutations in the imprinted gene MKRN3. , 2013, The New England journal of medicine.

[108]  R. Wevrick,et al.  Recommendations for the investigation of animal models of Prader–Willi syndrome , 2013, Mammalian Genome.

[109]  H. Herzog,et al.  Mouse models of Prader–Willi Syndrome: A systematic review , 2013, Frontiers in Neuroendocrinology.

[110]  Zhijian J. Chen,et al.  Regulation of WASH-Dependent Actin Polymerization and Protein Trafficking by Ubiquitination , 2013, Cell.

[111]  W. Colmers,et al.  Magel2 Is Required for Leptin-Mediated Depolarization of POMC Neurons in the Hypothalamic Arcuate Nucleus in Mice , 2013, PLoS genetics.

[112]  V. Matarazzo,et al.  Natural breaking of the maternal silence at the mouse and human imprinted Prader-Willi locus , 2013, Rare diseases.

[113]  M. Bertrand,et al.  Loss of Maged1 results in obesity, deficits of social interactions, impaired sexual behavior and severe alteration of mature oxytocin production in the hypothalamus. , 2012, Human molecular genetics.

[114]  M. Seaman The retromer complex – endosomal protein recycling and beyond , 2012, Journal of Cell Science.

[115]  B. Horsthemke,et al.  The imprinted NPAP1/C15orf2 gene in the Prader-Willi syndrome region encodes a nuclear pore complex associated protein. , 2012, Human molecular genetics.

[116]  D. Teis,et al.  The ESCRT machinery , 2012, Current Biology.

[117]  J. Resnick,et al.  Temporal and developmental requirements for the Prader–Willi imprinting center , 2012, Proceedings of the National Academy of Sciences.

[118]  D. Barlow Genomic imprinting: a mammalian epigenetic discovery model. , 2011, Annual review of genetics.

[119]  D. J. Driscoll,et al.  Unique and atypical deletions in Prader–Willi syndrome reveal distinct phenotypes , 2011, European Journal of Human Genetics.

[120]  G. Hertz,et al.  Prader-Willi syndrome: A primer for clinicians , 2011, International journal of pediatric endocrinology.

[121]  E. Dykens,et al.  Prader–Willi syndrome and autism spectrum disorders: an evolving story , 2011, Journal of Neurodevelopmental Disorders.

[122]  E. Keverne,et al.  Placental protection of the fetal brain during short-term food deprivation , 2011, Proceedings of the National Academy of Sciences.

[123]  R. Miyata,et al.  Decrease in acetylcholinergic neurons in the pedunculopontine tegmental nucleus in a patient with Prader‐Willi syndrome , 2011, Neuropathology : official journal of the Japanese Society of Neuropathology.

[124]  D. C. Driscoll,et al.  Nutritional phases in Prader–Willi syndrome , 2011, American journal of medical genetics. Part A.

[125]  Y. Sohn,et al.  Delayed Response of Amylin Levels after an Oral Glucose Challenge in Children with Prader-Willi Syndrome , 2011, Yonsei medical journal.

[126]  R. Wevrick,et al.  Impaired hypothalamic regulation of endocrine function and delayed counterregulatory response to hypoglycemia in Magel2-null mice. , 2011, Endocrinology.

[127]  F. Watrin,et al.  A single postnatal injection of oxytocin rescues the lethal feeding behaviour in mouse newborns deficient for the imprinted Magel2 gene. , 2010, Human molecular genetics.

[128]  S. Grambow,et al.  The metabolic phenotype of Prader-Willi syndrome (PWS) in childhood: heightened insulin sensitivity relative to body mass index. , 2010, The Journal of clinical endocrinology and metabolism.

[129]  P. Crock,et al.  Normal cortisol response on low-dose synacthen (1 microg) test in children with Prader Willi syndrome. , 2010, The Journal of clinical endocrinology and metabolism.

[130]  A. Belgorosky,et al.  Thyroid axis dysfunction in patients with Prader‐Willi syndrome during the first 2 years of life , 2010, Clinical endocrinology.

[131]  Maojun Yang,et al.  MAGE-RING protein complexes comprise a family of E3 ubiquitin ligases. , 2010, Molecular cell.

[132]  S. Luo,et al.  High-Resolution Analysis of Parent-of-Origin Allelic Expression in the Mouse Brain , 2010, Science.

[133]  J. Rosenfeld,et al.  Paternally inherited microdeletion at 15q11.2 confirms a significant role for the SNORD116 C/D box snoRNA cluster in Prader–Willi syndrome , 2010, European Journal of Human Genetics.

[134]  J. Christiansen,et al.  Normal cortisol response to high-dose synacthen and insulin tolerance test in children and adults with Prader-Willi syndrome. , 2010, The Journal of clinical endocrinology and metabolism.

[135]  E. Nillni Regulation of the hypothalamic Thyrotropin Releasing Hormone (TRH) neuron by neuronal and peripheral inputs , 2010, Frontiers in Neuroendocrinology.

[136]  M. Y. Kim,et al.  Correlation of adiponectin receptor expression with cytokines and insulin sensitivity in growth hormone (GH)-treated children with Prader-Willi syndrome and in non-GH-treated obese children. , 2010, The Journal of clinical endocrinology and metabolism.

[137]  S. O’Rahilly,et al.  A deletion of the HBII-85 class of small nucleolar RNAs (snoRNAs) is associated with hyperphagia, obesity and hypogonadism. , 2009, Human molecular genetics.

[138]  B. Grant,et al.  Pathways and mechanisms of endocytic recycling , 2009, Nature Reviews Molecular Cell Biology.

[139]  F. Benarroch,et al.  Primary Ovarian Dysfunction Contributes to the Hypogonadism in Women with Prader-Willi Syndrome , 2009, Hormone Research in Paediatrics.

[140]  J. Graves,et al.  Evolution of genomic imprinting: insights from marsupials and monotremes. , 2009, Annual review of genomics and human genetics.

[141]  R. Hochstenbach,et al.  A paternal deletion of MKRN3, MAGEL2 and NDN does not result in Prader–Willi syndrome , 2009, European Journal of Human Genetics.

[142]  R. Wevrick,et al.  Loss of Magel2, a Candidate Gene for Features of Prader-Willi Syndrome, Impairs Reproductive Function in Mice , 2009, PloS one.

[143]  R. Wevrick,et al.  Necdin, a Prader-Willi syndrome candidate gene, regulates gonadotropin-releasing hormone neurons during development. , 2008, Human molecular genetics.

[144]  F. Ceccato,et al.  Concomitant therapies (glucocorticoids and sex hormones) in adult patients with growth hormone deficiency. , 2008, Journal of endocrinological investigation.

[145]  B. Horsthemke,et al.  Mechanisms of imprinting of the Prader–Willi/Angelman region , 2008, American journal of medical genetics. Part A.

[146]  L. Wilkinson,et al.  Imprinted genes and neuroendocrine function , 2008, Frontiers in Neuroendocrinology.

[147]  Marwan Shinawi,et al.  Prader-Willi phenotype caused by paternal deficiency for the HBII-85 C/D box small nucleolar RNA cluster , 2008, Nature Genetics.

[148]  F. Sweep,et al.  High prevalence of central adrenal insufficiency in patients with Prader-Willi syndrome. , 2008, The Journal of clinical endocrinology and metabolism.

[149]  B. Lowell,et al.  Acute effects of leptin require PI3K signaling in hypothalamic proopiomelanocortin neurons in mice. , 2008, The Journal of clinical investigation.

[150]  U. Francke,et al.  SnoRNA Snord116 (Pwcr1/MBII-85) Deletion Causes Growth Deficiency and Hyperphagia in Mice , 2008, PloS one.

[151]  D. J. Driscoll,et al.  Pituitary abnormalities in Prader–Willi syndrome and early onset morbid obesity , 2008, American journal of medical genetics. Part A.

[152]  A. Holland,et al.  The phenomenology and diagnosis of psychiatric illness in people with Prader–Willi syndrome , 2008, Psychological Medicine.

[153]  S. Grambow,et al.  Altered distribution of adiponectin isoforms in children with Prader–Willi syndrome (PWS): association with insulin sensitivity and circulating satiety peptide hormones , 2007, Clinical endocrinology.

[154]  M. Tauber,et al.  KIGS Highlights: Growth Hormone Treatment in Prader-Willi Syndrome , 2007, Hormone Research in Paediatrics.

[155]  C. Stewart,et al.  Inactivation of the mouse Magel2 gene results in growth abnormalities similar to Prader-Willi syndrome. , 2007, Human molecular genetics.

[156]  M. P. Howell,et al.  The imprinted gene Magel2 regulates normal circadian output , 2007, Nature Genetics.

[157]  H. Duivenvoorden,et al.  Thyroid hormone levels in children with Prader–Willi syndrome before and during growth hormone treatment , 2007, Clinical endocrinology.

[158]  M. Butler,et al.  Plasma obestatin and ghrelin levels in subjects with Prader–Willi syndrome , 2007, American journal of medical genetics. Part A.

[159]  D. J. Driscoll,et al.  Whole genome microarray analysis of gene expression in an imprinting center deletion mouse model of Prader–Willi syndrome , 2007, American journal of medical genetics. Part A.

[160]  M. Theodoro,et al.  Thyroid function studies in Prader–Willi syndrome , 2007, American journal of medical genetics. Part A.

[161]  M. Solimena,et al.  Biogenesis of secretory granules. , 2006, Current opinion in cell biology.

[162]  Takaaki Kuwajima,et al.  Necdin Promotes GABAergic Neuron Differentiation in Cooperation with Dlx Homeodomain Proteins , 2006, The Journal of Neuroscience.

[163]  L. Enquist,et al.  Olfactory Inputs to Hypothalamic Neurons Controlling Reproduction and Fertility , 2005, Cell.

[164]  R. Ahima,et al.  Hormonal and metabolic defects in a prader-willi syndrome mouse model with neonatal failure to thrive. , 2005, Endocrinology.

[165]  R. Vettor,et al.  Increased serum resistin in adults with prader-willi syndrome is related to obesity and not to insulin resistance. , 2005, The Journal of clinical endocrinology and metabolism.

[166]  K. Kangawa,et al.  Ghrelin: structure and function. , 2005, Physiological reviews.

[167]  D. J. Driscoll,et al.  Prader-Willi syndrome. , 1984, Current problems in pediatrics.

[168]  E. Mignot,et al.  Hypocretin deficiency in Prader–Willi syndrome , 2005, European journal of neurology.

[169]  A. Razin,et al.  Establishing the epigenetic status of the Prader-Willi/Angelman imprinting center in the gametes and embryo. , 2004, Human molecular genetics.

[170]  J. Frystyk,et al.  Serum adiponectin levels in adults with Prader-Willi syndrome are independent of anthropometrical parameters and do not change with GH treatment. , 2004, European journal of endocrinology.

[171]  Z. Talebizadeh,et al.  Plasma Peptide YY and Ghrelin Levels in Infants and Children with Prader-Willi Syndrome , 2004, Journal of pediatric endocrinology & metabolism : JPEM.

[172]  S. Batalov,et al.  A gene atlas of the mouse and human protein-encoding transcriptomes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[173]  S. Lanzendorf,et al.  Expression of mRNAs for DNA methyltransferases and methyl‐CpG‐binding proteins in the human female germ line, preimplantation embryos, and embryonic stem cells , 2004, Molecular reproduction and development.

[174]  M. Thorén,et al.  Peptides associated with hyperphagia in adults with Prader-Willi syndrome before and during GH treatment. , 2003, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[175]  J. Bunt,et al.  High circulating ghrelin: a potential cause for hyperphagia and obesity in prader-willi syndrome. , 2002, The Journal of clinical endocrinology and metabolism.

[176]  A. Razin,et al.  The imprinting mechanism of the Prader–Willi/Angelman regional control center , 2002, The EMBO journal.

[177]  A. Holland,et al.  Prevalence of, and risk factors for, physical ill-health in people with Prader-Willi syndrome: a population-based study. , 2002, Developmental medicine and child neurology.

[178]  A. Orth,et al.  Large-scale analysis of the human and mouse transcriptomes , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[179]  Jimmy D Bell,et al.  Resting metabolic rate, plasma leptin concentrations, leptin receptor expression, and adipose tissue measured by whole-body magnetic resonance imaging in women with Prader-Willi syndrome. , 2002, The American journal of clinical nutrition.

[180]  A. Holland,et al.  Psychotic illness in people with Prader Willi syndrome due to chromosome 15 maternal uniparental disomy , 2002, The Lancet.

[181]  L. Seoane,et al.  Neuropeptide Y, but Not Agouti-Related Peptide or Melanin-Concentrating Hormone, Is a Target Peptide for Orexin-A Feeding Actions in the Rat Hypothalamus , 2002, Neuroendocrinology.

[182]  A. Hüttenhofer,et al.  The IC-SNURF-SNRPN transcript serves as a host for multiple small nucleolar RNA species and as an antisense RNA for UBE3A. , 2001, Human molecular genetics.

[183]  J. Walter,et al.  Maternal methylation imprints on human chromosome 15 are established during or after fertilization , 2001, Nature Genetics.

[184]  A. Hüttenhofer,et al.  Identification of brain-specific and imprinted small nucleolar RNA genes exhibiting an unusual genomic organization. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[185]  D. Abrous,et al.  Disruption of the mouse Necdin gene results in hypothalamic and behavioral alterations reminiscent of the human Prader-Willi syndrome. , 2000, Human molecular genetics.

[186]  A. Razin,et al.  The imprinting box of the Prader-Willi/Angelman syndrome domain , 2000, Nature Genetics.

[187]  A. Moncla,et al.  Auxological and Endocrine Evolution of 28 Children with Prader-Willi Syndrome: Effect of GH Therapy in 14 Children , 2000, Hormone Research in Paediatrics.

[188]  S. Saitoh,et al.  Parent-of-origin specific histone acetylation and reactivation of a key imprinted gene locus in Prader-Willi syndrome. , 2000, American journal of human genetics.

[189]  R. Nicholls,et al.  The ancient source of a distinct gene family encoding proteins featuring RING and C(3)H zinc-finger motifs with abundant expression in developing brain and nervous system. , 2000, Genomics.

[190]  B. Horsthemke,et al.  Identification of a testis-specific gene (C15orf2) in the Prader-Willi syndrome region on chromosome 15. , 2000, Genomics.

[191]  J. Santiago,et al.  Leptin concentrations in Prader‐Willi syndrome before and after growth hormone replacement , 2000, Clinical endocrinology.

[192]  B. Horsthemke,et al.  A 5-kb imprinting center deletion in a family with Angelman syndrome reduces the shortest region of deletion overlap to 880 bp , 1999, Human Genetics.

[193]  A. Berns,et al.  In vivo analysis of Frat1 deficiency suggests compensatory activity of Frat3 , 1999, Mechanisms of Development.

[194]  C. Stewart,et al.  Disruption of the mouse necdin gene results in early post-natal lethality , 1999, Nature Genetics.

[195]  T A Gray,et al.  An imprinted, mammalian bicistronic transcript encodes two independent proteins. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[196]  D. J. Driscoll,et al.  A novel imprinted gene, encoding a RING zinc-finger protein, and overlapping antisense transcript in the Prader-Willi syndrome critical region. , 1999, Human molecular genetics.

[197]  D. J. Driscoll,et al.  Imprinting of a RING zinc-finger encoding gene in the mouse chromosome region homologous to the Prader-Willi syndrome genetic region. , 1999, Human molecular genetics.

[198]  U. Francke,et al.  In vivo nuclease hypersensitivity studies reveal multiple sites of parental origin-dependent differential chromatin conformation in the 150 kb SNRPN transcription unit. , 1999, Human molecular genetics.

[199]  J. Leckman,et al.  Cerebrospinal fluid levels of oxytocin in Prader–Willi syndrome: a preliminary report , 1998, Biological Psychiatry.

[200]  M. Butler,et al.  Comparison of leptin protein levels in Prader-Willi syndrome and control individuals. , 1998, American journal of medical genetics.

[201]  F. Lönnqvist,et al.  Increased Leptin Messenger RNA and Serum Leptin Levels in Children with Prader-Willi Syndrome and Nonsyndromal Obesity , 1997, Pediatric Research.

[202]  M. Mattei,et al.  The Mouse Necdin Gene Is Expressed from the Paternal Allele Only and Lies in the 7C Region of the Mouse Chromosome 7, a Region of Conserved Synteny to the Human Prader-Willi Syndrome Region , 1997, European journal of human genetics : EJHG.

[203]  P. Putnam,et al.  Rectal bleeding in Prader-Willi syndrome. , 1996, Pediatrics.

[204]  D. J. Driscoll,et al.  Gene structure, DNA methylation, and imprinted expression of the human SNRPN gene. , 1996, American journal of human genetics.

[205]  D. Swaab,et al.  Alterations in the hypothalamic paraventricular nucleus and its oxytocin neurons (putative satiety cells) in Prader-Willi syndrome: a study of five cases. , 1995, The Journal of clinical endocrinology and metabolism.

[206]  T. Moore,et al.  Genomic imprinting in mammalian development: a parental tug-of-war. , 1991, Trends in genetics : TIG.

[207]  M. Butler Prader-Willi syndrome: current understanding of cause and diagnosis. , 1990, American journal of medical genetics.

[208]  G. Bray,et al.  The Prader‐Willi Syndrome: A Study of 40 Patients and a Review of the Literature , 1983, Medicine.

[209]  M. Tauber,et al.  Prader-Willi syndrome: Hormone therapies. , 2021, Handbook of clinical neurology.

[210]  D. G. Osborne,et al.  Monitoring receptor trafficking following retromer and WASH deregulation. , 2015, Methods in cell biology.

[211]  R. Ebstein,et al.  The role of oxytocin and vasopressin in emotional and social behaviors. , 2014, Handbook of clinical neurology.

[212]  H. Gerdes,et al.  Maturation of secretory granules. , 2010, Results and problems in cell differentiation.

[213]  D. J. Driscoll,et al.  Prader–Willi syndrome , 2009, European Journal of Human Genetics.

[214]  A. Holland,et al.  The course and outcome of psychiatric illness in people with Prader-Willi syndrome: implications for management and treatment. , 2007, Journal of intellectual disability research : JIDR.

[215]  Sang Eun Kim,et al.  Obestatin is not elevated or correlated with insulin in children with Prader-Willi syndrome. , 2007, The Journal of clinical endocrinology and metabolism.

[216]  R. Nicholls,et al.  Genome organization, function, and imprinting in Prader-Willi and Angelman syndromes. , 2001, Annual review of genomics and human genetics.